Close Menu

NEW YORK (360Dx) – Bio-Techne said today that its fiscal 2019 first quarter revenues rose 13 percent year over year, thanks largely to a 17 percent increase in revenues from its protein science business.

For the three months ended Sept. 30, the firm reported revenues of $163.0 million compared to $144.6 million in Q1 2018, beating the analysts' average estimate of $161.9 million. On an organic basis, revenues grew 10 percent year over year. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.